Boehringer Ingelheim - Focus on NSCLC treatment options
Live Q&A - 22 September 2020 - 17:00-17:30
Date
14 Sep 2020Session
Boehringer Ingelheim - Focus on NSCLC treatment optionsPresenters
Tanja CuferAuthors
T. CuferAuthor affiliations
- Department Of Medical Oncology, University Clinic Golnik, University of Ljubljana,, 4208 - Golnik/SI
Resources
Resources from the same session
Welcome and introduction
Presenter: Tanja Cufer
Session: Boehringer Ingelheim - Focus on NSCLC treatment options
Resources:
Webcast
Treatments After Progression in the First-Line of Non-Mutated NSCLC Adenocarcinoma
Presenter: Silvia Novello
Session: Boehringer Ingelheim - Focus on NSCLC treatment options
Resources:
Webcast
Uncommon EGFR mutations
Presenter: Xiuning Le
Session: Boehringer Ingelheim - Focus on NSCLC treatment options
Resources:
Webcast
The Future of NSCLC
Presenter: Melissa Johnson
Session: Boehringer Ingelheim - Focus on NSCLC treatment options
Resources:
Webcast
Key insights and closing remarks
Presenter: Tanja Cufer
Session: Boehringer Ingelheim - Focus on NSCLC treatment options
Resources:
Webcast